Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  sparfosic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 89 for your search:
Start Over
Master Protocol for Phase II-III Chemotherapy for Pancreatic Carcinoma --- PALA vs SAM (STZ/ADR/MeCCNU)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2279
Phase II/III Study of Continuous Infusion 5-FU with vs without Weekly PALA in Patients with Advanced Colorectal Adenocarcinoma (Summary Last Modified 11/89)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MAOP-5288, NCI-V89-0092
Phase II/III Study of Various Schedules of 5-FU Alone and with Modulation by CF or PALA in Patients with Disseminated Colorectal Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: SWOG-8905
Phase III Comparison of 5-FU vs 5-FU/PALA vs 5-FU/LEV vs 5-FU/MeCCNU/VCR/SZC vs 5-FU/TdR for Unresectable or Metastatic Colorectal Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-804651, MAYO-804651, NCCTG-80-46-51
Phase III Chemotherapy with PALA, AMSA, VM-26, and NCS as Single Agents in Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2579
Phase III Randomized, Intergroup Comparison of 5-FU vs 5-FU/PALA vs 5-FU/Oral CF vs 5-FU/Intravenous CF vs 5-FU/IFN-A in Patients with Advanced Colorectal Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-2290, CLB-9092, E2290
Phase I/II Chemotherapy with PALA/High-Dose MTX/5-FU plus Leukovorin Rescue in Patients with Metastatic Colorectal Carcinoma (Summary Last Modified 09/88)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 90
Sponsor: NCI
Protocol IDs: MSKCC-8460A, NCI-T84-0324W, T84-0324
Phase I/II Chemotherapy with High-Dose ARA-C plus Biochemical Modulation with PALA/Thymidine in Patients with CML in Blast Crisis and Relapsed Acute Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8433, NCI-T84-0418D, T84-0418
Phase II Study of Biochemical Modulation of 5-FU and 5-FU/CF with and without PALA in Patients with Resectable Colorectal Carcinoma (Summary Last Modified 07/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCCWFU-59193, NCI-T93-0137D, T93-0137
Phase II Chemotherapy with PALA, Bruceantin or Vindesine for non-Oat Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DT-7903
Phase II Chemotherapy with PALA for Metastatic Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DT-7942
Phase II Chemotherapy with PALA for Refractory Metastatic Sarcoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8015
Phase II Pilot Study of PALA Chemotherapy for Advanced Bronchogenic Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-LUN-P41
Phase II Chemotherapy with Single Agents Selected by Soft Agar Colony Sensitivity Studies for Advanced Renal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-805002, NCCTG-805002, NCI-W81-0587
Phase II Chemotherapy with PALA/L-Alanosine for Residual, Recurrent, or Metastatic Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-814603
Phase II Single-Agent Chemotherapy in Patients with Advanced Ovarian Carcinoma Using Agents Selected by Soft Agar Colony Sensitivity Studies
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-816101
Phase II Chemotherapy with PALA/TDR/5-FU for Advanced Dukes D Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DT-8133
Phase II Study of New Agents in Treatment of Advanced Stage IV Cancer of Head and Neck: MGBG
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2379
Phase II Chemotherapy with PALA/5-FU/TdR for Measurable Metastatic or Recurrent Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-824601, NCI-W82-1367, W82-1367
Phase II Chemotherapy with DAG/BCNU/PALA for Recurrent Primary Brain Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-817202, NCI-W81-0563
Phase II Therapy with PALA/L-Alanosine and with Cimetidine as a Single Agent for Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-837051, NCCTG-83-70-51
Phase II Chemotherapy with PALA/TDR/5-FU for Advanced Measurable Anaplastic Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-844851, MAYO-844851, NCCTG-84-48-51
Phase II Chemotherapy with PALA for Stage III/IV Ovarian Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: EORTC-55803
Start Over